about
Exome sequence identifies RIPK4 as the Bartsocas-Papas syndrome locusDlx genes, p63, and ectodermal dysplasias.Oncogenic Intra-p53 Family Member Interactions in Human CancersStructural basis of p63α SAM domain mutants involved in AEC syndromeRapp-Hodgkin syndrome and the tail of p63APR-246/PRIMA-1(MET) rescues epidermal differentiation in skin keratinocytes derived from EEC syndrome patients with p63 mutationsRole of p63 and the Notch pathway in cochlea development and sensorineural deafnessClaudin-1 is a p63 target gene with a crucial role in epithelial developmentTP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy.Prioritization of neurodevelopmental disease genes by discovery of new mutations.p63 exerts spatio-temporal control of palatal epithelial cell fate to prevent cleft palate.DNA-binding and transactivation activities are essential for TAp63 protein degradation.Mutations in PVRL4, encoding cell adhesion molecule nectin-4, cause ectodermal dysplasia-syndactyly syndrome.p63 and p73, the ancestors of p53.Analysis of large phenotypic variability of EEC and SHFM4 syndromes caused by K193E mutation of the TP63 gene.Characterization of two ectrodactyly-associated translocation breakpoints separated by 2.5 Mb on chromosome 2q14.1-q14.2.Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings.Regulation of Fertility by the p53 Family Members.TAp63γ and ΔNp63β promote osteoblastic differentiation of human mesenchymal stem cells: regulation by vitamin D3 Metabolites.Mutations in RIPK4 cause the autosomal-recessive form of popliteal pterygium syndrome.Orofacial clefting: recent insights into a complex traitGenome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiationAre interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?Gene p63: In ectrodactyly-ectodermal dysplasia clefting, ankyloblepharon-ectodermal dysplasia, Rapp-Hodgkin syndromeA new mutation in TP63 is associated with age-related pathology.The evolution of human genetic studies of cleft lip and cleft palate.Genome scan, fine-mapping, and candidate gene analysis of non-syndromic cleft lip with or without cleft palate reveals phenotype-specific differences in linkage and association resultsCurrent concepts in genetics of nonsyndromic cleftsA symphony of regulations centered on p63 to control development of ectoderm-derived structures.Edgotype: a fundamental link between genotype and phenotype.Differential recognition of response elements determines target gene specificity for p53 and p63Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site.FGF8, c-Abl and p300 participate in a pathway that controls stability and function of the ΔNp63α protein.MSX1 mutations and associated disease phenotypes: genotype-phenotype relations.Involvement of p63 in the herpes simplex virus-1-induced demise of corneal cells.Inhibition of p63 transcriptional activity by p14ARF: functional and physical link between human ARF tumor suppressor and a member of the p53 family.Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice.Genome-wide meta-analyses of nonsyndromic orofacial clefts identify novel associations between FOXE1 and all orofacial clefts, and TP63 and cleft lip with or without cleft palate.Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes.Small players with a big role: MicroRNAs in pathophysiology of cleft lip and palate.
P2860
Q24300588-3DC34E8C-44FC-4686-B7D1-BA1FD4C50FFAQ24535426-201BC092-53D7-4ABD-AF17-C6AC02C66343Q26749382-9B9B685E-8E9A-4C52-B38A-CB9FCF2A7087Q27668032-8CF91C88-C890-46BA-8BB5-726897EFEA97Q28236286-BC4FB414-E849-43FE-BEB9-A0E115B5A024Q28284341-F690DF34-F639-41BD-9F16-DF01C80FEA45Q30454583-74185117-445D-488A-B278-24AAFC05AE1FQ33354147-EBB53BD6-50AE-48B4-9DA7-E7309A81A721Q33358710-8F71730C-FEFB-41C1-9D53-A0D68A27DD06Q33830995-EA77DA25-17EA-4393-986C-05B0AB6D9A9EQ33834826-A6612907-8849-4720-B3DC-339F81975003Q33884223-54B8BC48-6BF7-4F63-A067-958EFF2D64B1Q34050968-03EE1FF9-BC1C-4D07-BD60-39492666346CQ34080237-C116C1EE-0577-4801-B4A4-8AF8D81F9A51Q34264505-A7008BF2-F0DE-4D1C-918B-D630FBC0F7C8Q34326926-5C6B74E0-1B9F-4844-A8E6-B7F29235A0F2Q35070144-51528ECA-7FA0-4674-BCC5-10D51D69738DQ35103149-38066444-A2FA-4FEB-867E-5DB8200F3C4BQ35303252-89E08573-917F-4DF2-8B69-8BE2526A1038Q35671532-D773E352-1A16-4499-9080-1AFDA08A1DCBQ36139769-224F7DFA-5209-443D-9046-786560AC0337Q36180219-7750528D-8396-4A05-B586-8B237643FCAAQ36777361-46F9316F-4365-4911-B6CD-0EC373B3924FQ36820268-56DE5ABB-647A-469D-A30C-B7C7EF8F78C1Q36869781-3180B8A2-2946-4772-B280-55C0D91A3DD8Q37139817-3DDD332E-7904-4161-AD55-E911DF7D45D8Q37258000-2DD6E522-04A1-494B-AA76-8EC7F0823C03Q37409808-6C6C3DF2-55AB-44AA-99A5-DE569616D329Q37895920-105A1228-0DE5-4E8A-83F1-06332E19A302Q38167225-74C80AF5-A6AE-42B4-B026-BF4D66174C6FQ38324246-BAE6EB5E-0E4C-42D8-92EC-EC70607B5C75Q38621771-FBEB77F0-C870-4F1C-9FBB-E5AC7A948460Q38882470-1D747C8E-A7C0-48C4-9491-C7995A02377BQ38887068-6A5A0E13-3D4B-409F-B238-E9B3CE72E2F7Q39696118-42F32159-DFEF-40B6-A42D-323D603826A8Q39998887-0C273C02-E990-4012-97B7-6573B17BFC6AQ40238247-661F402E-8747-416B-8730-29BE73307C5DQ40395576-93B2F872-9F20-4E48-B022-7053BC8DE63BQ40623341-39732F69-0723-419A-B74E-78489A197CC5Q40782808-9336B299-FB34-4046-B953-74921923CC5D
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Splitting p63
@ast
Splitting p63
@en
Splitting p63
@nl
type
label
Splitting p63
@ast
Splitting p63
@en
Splitting p63
@nl
prefLabel
Splitting p63
@ast
Splitting p63
@en
Splitting p63
@nl
P2860
P3181
P356
P1476
Splitting p63
@en
P2093
Han G Brunner
P2860
P3181
P356
10.1086/341450
P407
P577
2002-07-01T00:00:00Z